LENZ Therapeutics Balance Sheet (2022-2025) | LENZ

Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Accumulated Depreciation (Quarter) 1.29M1.87M2.52M3.21M3.86M3.27M0.84M
Assets
Current Assets
Cash & Equivalents (Quarter) 185.07M75.17M56.39M47.73M7.96M128.51M182.99M200.36M84.03M41.05M20.16M23.04M37.61M25.40M25.18M
Receivables - Net (Quarter) 0.33M
Receivables (Quarter) 0.33M
Inventory (Quarter) 1.67M1.68M2.46M2.49M2.06M0.04M0.95M2.94M
Prepaid Assets (Quarter) 0.75M0.18M2.05M1.34M0.67M0.02M1.23M3.28M3.12M3.48M2.77M3.77M3.97M3.88M5.80M
Current Assets (Quarter) 343.76M326.64M298.49M275.37M270.31M251.17M238.78M216.67M199.35M220.70M211.92M197.86M213.60M207.00M301.41M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 9.37M10.47M13.27M22.63M33.07M17.96M12.53M0.05M0.16M0.37M0.65M0.93M1.17M1.26M1.19M
Long-Term Investments (Quarter) 12.93M5.99M13.40M15.32M
Long-Term Deferred Tax (Quarter) 0.00M
Other Non-Current Assets (Quarter) 1.72M1.72M1.701.70M1.70M1.70M1.70M0.02M1.40M1.40M1.60M1.60M2.54M
Non-Current Assets (Quarter) 34.85M27.14M36.35M46.54M39.69M35.87M27.45M0.65M3.29M3.30M3.39M3.39M3.73M3.71M4.46M
Assets (Quarter) 378.61M353.79M334.85M321.90M310.00M287.04M266.23M217.32M202.64M224.01M215.30M201.25M217.33M210.70M305.88M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 3.07M3.62M3.97M2.61M1.99M2.72M3.75M7.13M4.41M2.76M4.26M3.66M2.85M4.32M4.17M
Payables (Quarter) 3.07M3.62M3.97M2.61M1.99M2.72M3.75M7.13M4.41M2.76M4.26M3.66M2.85M4.32M4.17M
Accumulated Expenses (Quarter) 0.50M2.18M1.30M1.87M1.31M3.79M1.90M11.76M4.18M4.95M6.15M4.91M7.54M11.99M17.02M
Other Accumulated Expenses (Quarter) 0.87M0.18M0.48M1.35M4.89M3.06M0.22M
Current Leases (Quarter) 5.64M4.90M4.60M4.04M3.10M2.91M3.40M
Total Current Liabilities (Quarter) 12.77M12.07M13.52M13.04M14.34M12.27M12.54M18.89M8.58M7.71M10.41M8.57M10.40M16.32M21.19M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 5.90M44.62M5.90M5.90M
Operating Leases (Quarter) 4.50M3.30M2.50M1.75M1.40M50.63M49.70M0.16M1.05M1.43M0.81M1.18M1.05M0.46M0.81M
Other Non-Current Liabilities (Quarter) 2.42M10.82M0.87M
Total Non-Current Liabilities (Quarter) 15.97M14.79M32.90M62.90M62.21M19.16M9.72M8.73M11.22M
Total Liabilities (Quarter) 17.31M15.33M18.39M25.61M33.77M62.90M62.21M19.16M9.72M8.73M11.22M9.24M10.97M16.78M21.54M
Shareholder's Equity
Common Equity (Quarter) 361.30M338.46M316.45M-24.17M-36.68M-51.21M-69.57M198.17M192.92M215.28M204.08M192.01M206.37M193.93M284.34M
Shareholder's Equity (Quarter) 361.30M338.46M316.45M-24.17M-36.68M-51.21M-69.57M198.17M192.92M215.28M204.08M192.01M206.37M193.93M284.34M
Liabilities and Shareholders Equity (Quarter) 378.61M353.79M334.85M321.90M310.00M287.04M266.23M217.32M202.64M224.01M215.30M201.25M217.33M210.70M305.88M
Retained Earnings (Quarter) -167.20M-193.12M-217.80M-242.40M-0.47M-0.27M-344.10M-111.90M-122.15M0.52M-145.01M0.12M-174.50M0.23M0.24M
Treasury Shares (Quarter) 0.08M0.15M0.15M0.03M
Shares Outstanding (Quarter) 58.01M58.21M58.15M1.95M1.95M57.99M57.97M25.50M25.85M27.48M27.52M27.54M28.50M28.59M31.34M